BackInstadose Pharma Overview

Instadose Pharma Receivables

Instadose Pharma's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Instadose Pharma Receivables History

Loading

Instadose Pharma vs. peers: Receivables Comparison

Loading

Instadose Pharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Instadose Pharma (INSD) FAQ

Instadose Pharma (INSD) currently reports a receivables of $0 as of February 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Instadose Pharma's receivables history and peer comparisons.

Instadose Pharma's receivables changed from $0 to $0 (period ending February 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Instadose Pharma reported $0 in receivables as of February 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Instadose Pharma, and consider following INSD for alerts when major investors trade the stock.

Questions & Answers